Halestrap AP, McStay GP, Clarke SJ
This fast-absorbing, stimulant-free liquid formula is designed to support energy production, metabolism, and workout performance
Individuals with type 2 diabetes and obesity face a high risk for developing cardiovascular disease and experiencing major cardiac events or conditions, including myocardial infarction, stroke, heart failure, cardiovascular death, and peripheral arterial disease
These meds have historically run upward of $1,000 without insurance (and coverage is still limited)though both Eli Lilly (Zepbound) and Novo Nordisk (Wegovy) have recently cut that price in half, to $499 a month, for folks without coverage who opt in to direct-pay programs with the drugmakers